Patent details
EP3730134
Title:
MEDICINAL COMPOSITION FOR PREVENTING OR TREATING SECONDARY HYPERPARATHYROIDISM UNDER MAINTENANCE DIALYSIS
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Unitary Effect
Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
10/06/2025
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
18/06/2025
Unitary Effect Date:
14/05/2025
Unitary Effect Registration Date:
18/06/2025
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP3730134
SPC Number:
Creation Date:
Basic Information
Publication number:
EP3730134
WO Application Number:
JP2018046679
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18893074.7
WO Publication Number:
WO2019124411
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Japan (JP)
Publications:
Dates
Filing date:
19/12/2018
Grant date:
14/05/2025
EP Publication Date:
28/10/2020
WO Publication Date:
27/06/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/05/2025
EP B1 Publication Date:
14/05/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
18/12/2038
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
14/05/2025
Name:
EA Pharma Co., Ltd.
Address:
2-1-1, Irifune
Chuo-ku, Tokyo 104-0042, Japan (JP)
Inventor
1
Name:
KATAOKA Daisuke
Address:
Tokyo 164-0011, Japan (JP)
2
Name:
KUYAMA Kazuo
Address:
Nagoya-shi
Aichi 461-8631, Japan (JP)
3
Name:
ASANO Kenji
Address:
Nagoya-shi
Aichi 461-8631, Japan (JP)
4
Name:
WAGATSUMA Hirotaka
Address:
Kawasaki-shi
Kanagawa 210-8681, Japan (JP)
5
Name:
TSURUTA Atsushi
Address:
Kawasaki-shi
Kanagawa 210-8681, Japan (JP)
6
Name:
TAKANOHASHI Toshiyuki
Address:
Kawasaki-shi
Kanagawa 210-8681, Japan (JP)
Priority
Priority Patent Number:
2017244149
Priority Date:
20/12/2017
Priority Country:
Japan (JP)
Classification
IPC or IDT classification:
A61K 31/198 ;
A61P 5/18 ;
C07C 275/42 ;
A61K 45/06 ;
A61K 33/06 ;
A61K 31/59 ;
Publication
Bulletin
1
Bulletin Heading:
UP1
Journal edition number:
30/25
Publication date:
28/07/2025
Description:
European patents with registered Unitary Effect
2
Bulletin Heading:
EP2
Journal edition number:
20/25
Publication date:
14/05/2025
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202536
Publication date:
03/09/2025
Description:
Document reprinted after correction (B8, B9)
2
Issue number:
202530
Publication date:
23/07/2025
Description:
Unitary Effect Request Acceptance
3
Issue number:
202529
Publication date:
16/07/2025
Description:
Unitary Effect Request Receipt
4
Issue number:
202520
Publication date:
14/05/2025
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type